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Abstract
Background. Loss of residual renal function (RRF)
contributes to anaemia, inflammation and malnutri-
tion and is also a strong predictor of mortality in
continuous ambulatory peritoneal dialysis (CAPD)
patients. However, the role of RRF on peritonitis is
not yet clearly established. This study aimed to
evaluate the effect of RRF on the development of
peritonitis.
Methods. Study subjects were 204 end-stage renal
disease (ESRD) patients who started PD from January
2000 to December 2005. Biochemical and clinical data
within 1 month of PD commencement were considered
as baseline. To determine risk factors for peritonitis,
multivariate Cox regression was performed. Kaplan–
Meier analysis and log-rank test were used to examine
the difference of peritonitis-free period according to
the presence of diabetes and RRF.
Results. On univariate analysis based on baseline data
in first peritonitis, diabetes was less prevalent and
RRF (6.7 2.6 vs 4.0 2.3ml/min/1.73m2, P< 0.01),
haemoglobin (10.9 1.2 vs 10.6 1.2 g/dl, P< 0.05)
and serum albumin level (3.6 0.4 vs 3.4 0.4 g/dl,
P< 0.01) were significantly higher in the peritonitis-
free group. Kaplan–Meier analysis showed that time to
first PD peritonitis episode was significantly longer in
the non-diabetic patients (P< 0.001) and in patients
with higher residual GFR (P< 0.001). Multivariate
analysis showed that diabetes [hazard ratio(HR) 1.64,
P< 0.05] and RRF (per 1ml/min/1.73m2 increase, HR
0.81, P< 0.01) were independent risk factors.
Conclusion. Our study revealed that RRF and diabetes
were risk factors for peritonitis. These results suggest
that preservation of RRF should be viewed as a
protective strategy to reduce peritonitis.
Keywords: peritonitis; residual renal function;
diabetes
Introduction
Continuous ambulatory peritoneal dialysis (CAPD) is
an established treatment modality in end-stage renal
disease (ESRD) patients and 150 000 patients are
being maintained on CAPD worldwide [1]. Although
the incidence of peritonitis has decreased significantly
since the introduction of the (53) Y-set system [2,3],
PD peritonitis still remains as the leading cause of
technique failure in CAPD patients. Factors related
to PD peritonitis include diabetes, hypoalbuminaemia,
catheter connection technique, age, PD modality,
positive staphylococcal nasal carrier status, etc. [3–7].
For the last decade, the importance of residual renal
function (RRF) has become evident in CAPD patients
[8,9]. Decline of RRF is associated with fluid overload
[10], anaemia [11], inflammation [12], malnutrition [13]
and mortality [14–15]. However, a role of RRF on the
development of peritonitis is not yet established.
We undertook this study to investigate risk factors
for PD peritonitis and elucidate the effect of RRF on
the development of peritonitis.
Patients and methods
Patient selection and data collection
This is a single-centre study with retrospective data collec-
tion. Study subjects were 240 ESRD patients who started
CAPD from January 2000 to December 2005 and had urea
kinetic studies including measurements of RRF within
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3 months of CAPD initiation. Sixteen patients who had been
undergoing haemodialysis prior to CAPD initiation were
excluded because most of these subjects were anuric. Also,
eight patients who received kidney transplantation before
CAPD were also excluded due to long-term use of an
immunosuppressive agent. Twelve patients whose medical
records were not available or data were not eligible were also
excluded. Therefore, 204 patients were included in this study.
All procedures of CAPD catheter insertion were performed
by nephrologists. On the day of surgery, a prophylactic
antibiotic (cefazolin sodium 1.0g) was administered intrave-
nously 2 h before catheter insertion. The twin-bag system was
employed in all patients and different kinds of PD fluid
(Baxter Healthcare, Deerfield, Illinois, USA, Fresenius
Medical Care, Deutschland GmbH, Germany and Gambro,
Lund, Sweden) were used.
The management of PD peritonitis was followed by
International Society for Peritoneal Dialysis (ISPD) commit-
tee guidelines [16,17].
Demographic and clinical data were collected based on
retrospective review of patient records; sex, age, body mass
index (BMI) calculated as weight/(height)2, primary renal
disease, duration of dialysis, time to first peritonitis episode,
exit site infection (ESI), use of biocompatible PD solution,
and use of automated PD (APD). The following laboratory
data obtained within 1 month after CAPD commencement
were considered as baseline; haemoglobin, BUN, creatinine,
albumin, total cholesterol, ferritin, ESR, CRP, residual
GFR, Kt/V urea, normalized protein catabolic rate (nPCR)
and percentage of lean body mass (%LBM) [18]. Residual
GFR was calculated as an average of urea and creatinine
clearance from a 24 h urine collection [19].
Statistical analysis
Statistical analysis was performed using SPSS for Windows
software, version 12.0 (SPSS Inc., Chicago, IL, USA). All
data were expressed as mean SD. To compare the
difference between peritonitis group and peritonitis-free
group, Student’s t-test was used for continuous variables
and chi-square test was used for categorical variables. To
determine risk factors for peritonitis, multivariate Cox
regression was performed. Kaplan–Meier analysis and log-
rank test were used to examine the difference of peritonitis-
free period according to the presence of diabetes and RRF.
Data were defined as censored if death and transfer to
haemodialysis or renal allograft occurred. All probabilities
were two-tailed and the level of significance was set at 0.05.
Results
Demographic and clinical data
Table 1 details baseline characteristics of 204 patients.
Mean age of patients was 54 years and 57% were
males. Diabetes was the most common cause of
ESRD in this study (34.8%). All diabetic patients
had type 2 diabetes. Baseline mean concentrations of
haemoglobin and serum albumin were 10.7 1.2 g/dl
(107 12 g/l), and 3.5 0.4 g/dl (35 4 g/l), respec-
tively. Baseline residual glomerular filtration rate
(GFR) was 5.2 2.8ml/min/1.73m2. A total of 195
episodes of PD peritonitis were observed in 110 patients
during the follow-up period (total 650.2 patient-years).
Mean peritonitis rate was 0.30 per patient-year.
Staphylococcus coagulase negative (21.0%) was the
most common causative organism (Table 2).
Analysis of risk factors for peritonitis
Patients were classified as peritonitis-free (n¼ 94)
and peritonitis group (n¼ 110). Table 3 presents
the differences between these two groups. In the
peritonitis-free group, diabetes was less prevalent and
residual GFR and levels of haemoglobin and serum
albumin at baseline were significantly higher than
those observed in the peritonitis group (Table 3).
Table 1. Demographic and baseline clinical data (n¼ 204)
Gender (male/female) 117/87
Age (years) 54.0 11.5
Type of CKD
Diabetes 71 (34.8%)
Chronic glomerulonephritis 45 (22.1%)
Hypertension 32 (15.7%)
Others 20 (9.8%)
Unknown 36 (17.6%)
Mean follow-up duration (months) 37.5 17.2
Use of automated PD 14 (6.9%)
Haemoglobin (g/dl) 10.7 1.2
Albumin (g/dl) 3.5 0.4
BUN (mg/dl) 57.3 19.7
Creatinine (mg/dl) 9.0 2.7
Residual GFR (ml/min/1.73m2) 5.2 2.8
Serum ferritin (mg/dl) 191.6 156.1
CRP (mg/dl) 0.49 0.46
Lean body mass (% body weight) 73.9 12.7
nPCR (g/kg/day) 1.0 0.2
Kt/V urea 2.3 0.5
Total peritonitis episodes during follow-up 195
Overall peritonitis rates (per patient-year) 0.30
Values are expressed as meanSD. All data were measured within
1 month of CAPD initiation.
Table 2. Micro-organisms in patients with peritonitis
Causative organisms Peritonitis
episodes
Percentage (%)
Gram (þ) 84 43.1
Staphylococcus
coagulase negative
41 21.0
Methicillin sensitive 31 15.9
Methicillin resistant 10 5.1
Staphylococcus aureus 29 17.0
Methicillin sensitive 18 10.5
Methicillin resistant 11 6.5
Other Gram (þ) 9 5.3
Gram () 46 26.9
Escherichia coli 15 7.7
Pseudomonas species 19 9.7
Other Gram () 20 10.3
Culture negative 50 25.6
Fungus 7 3.6
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Multivariate Cox regression showed that diabetes and
RRF were independent risk factors for first PD
peritonitis when adjusted for age, haemoglobin,
serum albumin and exit site infection (Table 4).
When residual GFR was not considered in the multi-
variate model, hypoalbuminaemia was a significant
determinant for peritonitis (Table 4, model 1). Kaplan–
Meier analysis showed that time to first PD peritonitis
episode was significantly longer in non-diabetic
patients (Figure 1, P< 0.001) and in patients with
higher residual GFR (Figure 2, P< 0.001).
Comparison of peritonitis rate and other parameters
according to the baseline GFR
Table 5 shows differences of peritonitis rate, time to
first peritonitis episode, and other parameters between
patients with RRF over 5ml/min/1.73m2 and those
with RRF <5ml/min/1.73m2. The former group
experienced significantly less peritonitis episodes com-
pared with the latter group (0.24 vs 0.57 episodes per
patient-year, P< 0.01). Similarly, time to first perito-
nitis episode was significantly longer and haemoglobin
and serum albumin level were significantly higher in
patients with residual GFR >5ml/min/1.73m2.
Discussion
In the present study, we found that reduced RRF and
diabetic status were independent risk factors for
peritonitis in CAPD patients. An important finding
Table 3. Comparison between peritonitis-free and peritonitis group
Peritonitis-free
(n¼ 94)
Peritonitis
(n¼ 110)
Age (years) 53.3 11.4 54.6 11.6
Gender (male : female) 55 : 39 62 : 48
BMI (kg/m2) 22.9 3.5 23.0 2.8
DM 22 (23.4%) 49 (44.5%)
Use of biocompatible
dialysate
27 (34.6%) 25 (28.7%)
Exit site infection 11 (11.7%) 18 (16.4%)
Residual GFR
(ml/min/1.73m2)
6.7 2.6 4.0 2.3
Follow-up duration
(months)
36.3 15.2 38.4 18.5
Time to first peritonitis – 20.7 12.7
Haemoglobin (g/dl) 10.9 1.2 10.6 1.2y
Log10ferritin (mg/dl) 2.20 0.22 2.13 0.38
BUN (mg/dl) 56.1 17.9 58.3 21.1
Creatinine (mg/dl) 9.0 2.7 9.0 2.7
Albumin (g/dl) 3.6 0.4 3.4 0.4
Total cholesterol (mg/dl) 177.0 34.3 180.6 41.7
Log10CRP (mg/dl) 0.41 0.26 0.48 0.40
Kt/V urea 2.3 0.5 2.3 0.5
Lean body mass
(% body weight)
76.4 12.0 70.9 13.0
nPCR (g/kg/day) 1.02 0.21 0.97 0.20
Mean D/P creatinine
at 4 h
0.71 0.09 0.69 0.11
Values are expressed as meanSD. All data were measured
within 1 month of CAPD initiation.
P< 0.01, yP< 0.05 vs peritonitis-free group.
Table 4. Multivariate Cox regression for first peritonitis episode
Model HR (95% confidence
interval)
Model 1: Age, DM, haemoglobin,
exit site infection, serum albumin
Age (per 1 year increase) 0.99 (0.98–1.01)
DM (vs non-DM) 1.72 (1.15–2.60)
Haemoglobin (per 1 g/dl increase) 0.91 (0.77–1.02)
Exit site infection (yes vs no) 0.98 (0.59–1.63)
Serum albumin (per 1 g/dl increase) 0.51 (0.31–0.82)y
Model 2: Model 1þResidual GFR
DM (vs non-DM) 1.64 (1.08–2.50)y
Serum albumin (per 1 g/dl increase) 0.61 (0.37–1.13)
Residual GFR
(per 1ml/min/1.73m2 increase)
0.81 (0.74–0.88)
P< 0.01, yP< 0.05.
Fig. 1. Kaplan–Meier plot for probability of remaining peritonitis-
free according to diabetes status. Time to first PD peritonitis episode
was significantly longer in non-diabetic patients (P< 0.001).
Fig. 2. Kaplan–Meier plot for probability of remaining
peritonitis-free according to baseline residual renal function. Time
to first PD peritonitis episode was significantly longer in patients
with higher residual GFR. (A vs B, P< 0.001; A vs C, P< 0.001; B vs
C, P¼ 0.02).
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of our study is the fact that baseline RRF was
identified as a risk factor for PD peritonitis. There
have been numerous reports indicating poor clinical
outcome in CAPD patients with lower residual GFR
[10–15]. Recently, RRF has been studied in relation-
ship to outcome of peritonitis. [20–22]. An observa-
tional study of Szeto et al. [21] reported that adult
CAPD patients with better RRF experienced fewer
peritonitis episodes, although this study was not aimed
at examining the risk factors of PD peritonitis. Perez
Fontan et al. [22] reported that lower residual GFR
was an independent risk factor for at least one episode
of peritonitis and its related mortality. Liu et al. [23]
reported that loss of RRF was the most significant
factor in predicting poor outcome in CAPD patients
with fungal peritonitis. Our results clearly indicate that
time to first peritonitis episode was significantly longer
and peritonitis rate was significantly lower in patients
with residual GFR >5ml/min/1.73m2 compared with
those with GFR <5ml/min/1.73m2 (Figure 2, 0.24 vs
0.57 episodes per patient-year, P< 0.001). Also,
patients with residual GFR between 2 and 5ml/min/
1.73m2 experienced less peritonitis compared with
those patients with residual GFR <2ml/min/1.73m2
(0.49 vs 0.68 episodes per patient-year, P< 0.05).
Underlying mechanisms for this preventive effect of
RRF on PD peritonitis are unclear. It is possible
that patients with better preserved RRF might have
better immune defense mechanisms along with a
better preserved nutritional status. Actually, it has
been reported that RRF independently affects
the nutritional status of CAPD patients [13,21].
Also, nutritional status was reported as a significant
predictor for PD peritonitis [29,30]. In our study,
serum albumin level which might reflect nutritional
status was significantly higher in patients with residual
GFR >5ml/min/1.73m2 compared with those with
GFR <5ml/min/1.73m2. Other nutritional markers
such as BMI and %LBM were also higher in the
former group, although the differences were not
statistically significant (Table 5). Based on these
findings, it is tempting to postulate that the preventive
effect of RRF on peritonitis is mediated, at least
partially, by the better preserved nutritional status.
However, other unidentified mechanisms may also
play a role and this remains to be explored.
Contrary to our results, previous studies reported
that baseline serum albumin level was a significant
determinant for PD peritonitis [24,28,29]. One possible
explanation for this is that residual GFR was not
considered for the risk analysis in the previous reports.
It should be noted that lower albumin level was also
identified as an independent risk factor when baseline
data were analysed excluding RRF in the present study
(Table 4, model 1). To further ascertain the role of
hypoalbuminaemia on peritonitis, we conducted a risk
analysis of second peritonitis (recurrence), in those
patients who experienced the first peritonitis. The
effects of RRF were hardly expected as mean residual
GFR was <1.5ml/min/1.73m2 in recurrence and
recurrence-free groups. In this analysis, hypoalbumi-
naemia was a significant determinant of second
peritonitis along with the diabetic status (data not
shown). These findings together suggest that lower
albumin level contributes to the development of
peritonitis.
The fact that hypoalbuminaemia became insignif-
icant when RRF was considered in the multivariate
model suggests that there might be an interaction
between RRF and albumin level. To examine this
possibility, we then tested the interaction term of RRF
and serum albumin using a Cox proportional hazard
model. When the interaction term was included in a
multivariate model, there was a significant interaction
between the two variables (P< 0.01, data not shown).
This finding implies that serum albumin level is
significantly affected by RRF.
A recent observational study from Hong Kong
found that CAPD patients with diabetes were at
particularly high risk for peritonitis [24], which was
in agreement with our results. Diabetic patients
experienced more peritonitis episodes than non-
diabetic patients (0.63 vs 0.27 episodes per patient-
year, P< 0.01). Diabetes was reported to have an
unfavourable effect on migration of phagocytic cells
into the peritoneum, resulting in impaired immunity of
peritoneal defence mechanism [25]. Advanced glyca-
tion end (AGE) products produced in diabetic condi-
tion were also found to be detrimental to phagocytic
activity of peritoneal macrophages [26]. In addition,
bacterial overgrowth in the gastrointestinal tract
appeared to be a contributing factor for peritonitis in
CAPD patients with diabetes [27]. Insulin mixed to
Table 5. Comparison of peritonitis rate and other parameters
according to the baseline GFR
Residual GFR
>5ml/min/
1.73m2
(n¼ 107)
5ml/min/
1.73m2
(n¼ 97)
Age (years) 55.4 9.8 52.5 13.0
Gender (male: female) 65: 42 52: 45
BMI (kg/m2) 23.2 3.4 21.6 2.7
DM 37 (34.6%) 34 (35.1%)
Residual GFR
(ml/min/1.73m2)
7.3 2.2 3.0 1.2
Peritonitis rate
(episodes per
patient-year)
0.24 0.57
Time to first peritonitis
(months)
28.5 22.7 20.7 15.3y
Haemoglobin (g/dl) 10.8 1.2 10.6 1.3
BUN (mg/dl) 54.5 18.4 60.3 20.6y
Creatinine (mg/dl) 8.2 2.6 9.8 2.5
Albumin (g/dl) 3.7 0.5 3.4 0.4
Total cholesterol (mg/dl) 179.3 37.7 178.6 39.4
Kt/V urea 2.4 0.5 2.2 0.4y
Lean body mass
(% body weight)
74.2 13.3 70.6 12.1
nPCR (g/kg/day) 1.01 0.22 0.98 0.19
P< 0.01, yP< 0.05 vs patients with residual GFR> 5ml/min/
1.7m2.
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dialysate could be a route for peritonitis in diabetic
patients. However, we do not recommend such a
treatment to avoid a risk of peritonitis, thus all patients
were treated with oral hypoglycaemic agents or
subcutaneous insulin. Therefore, increased episodes
of peritonitis in diabetic patients were unlikely to be
caused by insulin mixed to dialysate. Also, the effect of
diabetes on the development of peritonitis appears to
be independent of RRF or albumin level since these
variables were not different between diabetic and non-
diabetic patients (data not shown).
Other factors previously reported as potential risk
factors for PD peritonitis were age [5], dialysis modality
[6], anaemia [31], economic status [32] and exit site
infection [33]. However, the results of studies on these
factors were controversial. De Vecchi et al. [5] reported
that the peritonitis rate was higher in the elderly
patients. On the contrary, Holley et al. [4] reported
that older age per se was not associated with higher
peritonitis rates. In our study, age was not found to be a
risk factor for PD peritonitis. Only 10 patients using
APD were included in this study and their mean
peritonitis rate was 0.32 episodes per patient-year,
which was not different from the non-APD patients
(0.30 episodes per patient-year, P¼ 0.92).
There are several limitations in the present study. This
is an observational study based on retrospective data
collection with relatively small sample size. Hence, the
causality of our findings needs further confirmation.
Also, other potential risk factors such as socioeconomic
status or personal hygiene were not considered in the
analysis. We have not included other relevant data
representing overall nutritional status such as subjective
global assessment (SGA) to fully assess the impact of
nutritional status. High incidence of culture-negative
peritonitis was another drawback. Despite these limita-
tions, it should be noted that RRF was identified as an
independent risk factor for peritonitis in this study.
There have been few studies in the past documenting the
importance of RRF in association with peritonitis
development in PD patients. A prospective study with
a large number of patients is needed to verify risk
factors identified in this study.
In conclusion, this study shows that RRF and
diabetes are independent risk factors for PD peritoni-
tis. After a decline or loss of RRF, lower serum
albumin level appeared to play a significant role in the
development of peritonitis. These results suggest that
preservation of RRF should be viewed as a protective
strategy to reduce peritonitis.
Conflict of interest statement. None declared.
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